← Insider buys
KRTX

Karuna Therapeutics, Inc.

Chief Medical Officer Stephen K. Brannan sold $1.0M of Karuna Therapeutics, Inc.

Sold$1,037,550
$207.51Price
5,000Shares
−25%Stake

What KRTX did after the filing

Prices for KRTX after this filing aren't in yet.

Traded Mon, Oct 10. Filed Wed, Oct 12, 1:01 PM ET, during the session. Not investment advice.